and at least one post-baseline value of the response variable were available. Table 1: Baseline characteristics 6·06·57·07·58·08·59·0 Exenatide (n=228)  Insulin glargine (n=220)Least-squares mean HbA1c(%) 6·06·57·07·58·08·59·09·510·010·5 Exenatide (n=216)Insulin glargine (n=209) Time (weeks) 0 8 18 26 36 48 60 72 84 96 108 120 132 144 156 Time (weeks)Time (weeks) Least-squares mean fasting serum glucose concentration (mmol/L) 0300 h Before breakfastAfter breakfastBefore lunchAfter lunchBefore dinnerAfter dinnerBedtime6·07·08·09·010·011·012·0 Exenatide (n=230)Insulin glargine (n=220)Least-squares mean self-monitored blood glucose concentration (mmol/L) –4·0–3·0–2·0–1·00·01·02·03·04·0 Exenatide (n=233)Insulin glargine (n=222)Least-squares mean bodyweight (kg)A CB D84 72 60 48 36 0 8 18 0 14 26 48 26 96 108 120 132 144 156 108 156 Figure 2: Primary and secondary eﬃ   cacy measures